Csaba Farsang

Summary

Country: Hungary

Publications

  1. doi request reprint Efficacy and Tolerability of Fixed-Dose Combination of Perindopril/Indapamide in Type 2 Diabetes Mellitus: PICASSO Trial
    Csaba Farsang
    St Imre University Teaching Hospital, Tétényi u 12 16, Budapest, 1115, Hungary
    Adv Ther 31:333-44. 2014
  2. doi request reprint Blood pressure and metabolic efficacy of fixed-dose combination of perindopril and indapamide in everyday practice
    Csaba Farsang
    Cardiometabolic Centre, St Imre Teaching Hospital, Budapest H 1115, Hungary
    Blood Press 22:3-10. 2013
  3. pmc Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk
    Csaba Farsang
    Cardiometabolic Center, Department of Internal Medicine, St Imre Hospital, Budapest, Hungary
    Vasc Health Risk Manag 7:605-22. 2011
  4. pmc Blood pressure control and components of the metabolic syndrome: the GOOD survey
    Walter Zidek
    Medizinische Klinik IV Endocrinology and Nephrology, Charite, Berlin, Germany
    Cardiovasc Diabetol 8:51. 2009
  5. doi request reprint Where are we with the management of hypertension? From science to clinical practice
    Csaba Farsang
    Cardiometabolic Department, St Imre Teaching Hospital, Budapest, Hungary
    J Clin Hypertens (Greenwich) 11:66-73. 2009
  6. doi request reprint Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey
    C Farsang
    The Cardiometabolic Centre, St Imre Hospital, Budapest, Hungary
    J Hum Hypertens 23:316-24. 2009
  7. ncbi request reprint Blood pressure control and response rates with zofenopril compared with amlodipine in hypertensive patients
    Csaba Farsang
    First Department of Internal Medicine, Semmelweiss University, Budapest, Hungary
    Blood Press Suppl 16:19-24. 2007
  8. ncbi request reprint Effects of rilmenidine on 24-h rhythmicity of blood pressure and spontaneous baroreflex sensitivity in essential hypertensive subjects
    Ervin Finta
    Department of Internal Medicine, Szent Imre Hospital, Budapest, Hungary
    J Hypertens 24:1619-25. 2006
  9. ncbi request reprint Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS)
    Csaba Farsang
    First Department of Internal Medicine, St Imre Teaching Hospital, Budapest, Hungary
    Curr Med Res Opin 19:205-17. 2003
  10. ncbi request reprint Blood pressure control and response rates with zofenopril compared with amlodipine in hypertensive patients
    Csaba Farsang
    First Department of Internal Medicine, Semmelweiss University, Budapest, Hungary
    Blood Press Suppl 2:19-24. 2007

Detail Information

Publications13

  1. doi request reprint Efficacy and Tolerability of Fixed-Dose Combination of Perindopril/Indapamide in Type 2 Diabetes Mellitus: PICASSO Trial
    Csaba Farsang
    St Imre University Teaching Hospital, Tétényi u 12 16, Budapest, 1115, Hungary
    Adv Ther 31:333-44. 2014
    ..Hypertension and type 2 diabetes mellitus (T2DM) synergistically deteriorate the vascular environment, making blood pressure reduction challenging, and substantially increasing cardiovascular risk...
  2. doi request reprint Blood pressure and metabolic efficacy of fixed-dose combination of perindopril and indapamide in everyday practice
    Csaba Farsang
    Cardiometabolic Centre, St Imre Teaching Hospital, Budapest H 1115, Hungary
    Blood Press 22:3-10. 2013
    ..Perindopril/indapamide is an effective and safe antihypertensive treatment in everyday medical practice...
  3. pmc Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk
    Csaba Farsang
    Cardiometabolic Center, Department of Internal Medicine, St Imre Hospital, Budapest, Hungary
    Vasc Health Risk Manag 7:605-22. 2011
    ..This review discusses the clinical evidence supporting the different indications for each of the ARBs and the outstanding safety of this drug class...
  4. pmc Blood pressure control and components of the metabolic syndrome: the GOOD survey
    Walter Zidek
    Medizinische Klinik IV Endocrinology and Nephrology, Charite, Berlin, Germany
    Cardiovasc Diabetol 8:51. 2009
    ..This analysis aimed to investigate which components of the metabolic syndrome are primarily associated with poor blood pressure control...
  5. doi request reprint Where are we with the management of hypertension? From science to clinical practice
    Csaba Farsang
    Cardiometabolic Department, St Imre Teaching Hospital, Budapest, Hungary
    J Clin Hypertens (Greenwich) 11:66-73. 2009
    ..Choosing the proper drugs and correct doses are important considerations for the long-term management of hypertension...
  6. doi request reprint Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey
    C Farsang
    The Cardiometabolic Centre, St Imre Hospital, Budapest, Hungary
    J Hum Hypertens 23:316-24. 2009
    ....
  7. ncbi request reprint Blood pressure control and response rates with zofenopril compared with amlodipine in hypertensive patients
    Csaba Farsang
    First Department of Internal Medicine, Semmelweiss University, Budapest, Hungary
    Blood Press Suppl 16:19-24. 2007
    ..Thus, given the size of the BP reduction, such treatments are likely to produce beneficial cardiovascular outcome effects in patients with mild to moderate hypertension...
  8. ncbi request reprint Effects of rilmenidine on 24-h rhythmicity of blood pressure and spontaneous baroreflex sensitivity in essential hypertensive subjects
    Ervin Finta
    Department of Internal Medicine, Szent Imre Hospital, Budapest, Hungary
    J Hypertens 24:1619-25. 2006
    ..To study the effects of the centrally acting imidazoline-like compound rilmenidine on the circadian and short-term cardiovascular rhythms derived from continuous blood pressure (BP) recordings in patients with mild essential hypertension...
  9. ncbi request reprint Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS)
    Csaba Farsang
    First Department of Internal Medicine, St Imre Teaching Hospital, Budapest, Hungary
    Curr Med Res Opin 19:205-17. 2003
    ....
  10. ncbi request reprint Blood pressure control and response rates with zofenopril compared with amlodipine in hypertensive patients
    Csaba Farsang
    First Department of Internal Medicine, Semmelweiss University, Budapest, Hungary
    Blood Press Suppl 2:19-24. 2007
    ..Thus, given the size of the BP reduction, such treatments are likely to produce beneficial cardiovascular outcome effects in patients with mild to moderate hypertension...
  11. ncbi request reprint Improving control of hypertension by an integrated approach -- results of the 'Manage it well!' programme
    Laszlo A Szirmai
    National Institute for Sports and Health, Semmelweis University of Medicine, Budapest, Hungary
    J Hypertens 23:203-11. 2005
    ..Patient non-compliance is a significant contributor to poor blood pressure control. Although measures to improve compliance are known, they are not in routine use...
  12. ncbi request reprint Non-invasive assessment of microvascular endothelial function by laser Doppler flowmetry in patients with essential hypertension
    Katalin Farkas
    1st Department of Internal Medicine, St Imre Teaching Hospital, Tétényi u 12 16, Budapest 1115, Hungary
    Atherosclerosis 173:97-102. 2004
    ..8 +/- 5.5 and 68.9 +/- 6.1% (P = 0.157, NS) in EHT and in NT, respectively. These results demonstrate that essential hypertension is associated with endothelial dysfunction in the skin microcirculation of the forearm...
  13. ncbi request reprint Treatment of hypertension in dialysed patients
    Istvan Kiss
    Department of Nephrology Hypertension, St Imre Teaching Hospital, Semmelweis University Medical Faculty, Budapest, Hungary
    J Hypertens 23:222-6. 2005